Skip to content

Evaluation study of preventing exacerbations for home care patients with chronic diseases by using dual-monitoring-based telenursing system-a prospective longitudinal mixed methods study

Evaluation study of preventing exacerbations for home care patients with chronic diseases by using dual-monitoring-based telenursing system-a prospective longitudinal mixed methods study - Evaluation study of preventing exacerbations for home care patients by using dual-monitoring-based telenursing system-a prospective longitudinal mixed methods study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041160
Enrollment
42
Registered
2020-08-01
Start date
2020-08-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, IPF, Post-aspiration pneumonia, Diabetes, Amyotrophic lateral sclerosis, Congestive heat failure, Lung cancer, COVID-19

Interventions

Using a telenursing system

Sponsors

St. Luke's International University Graduate School
Lead Sponsor
Tokyo Healthcare University, Tokyo Metropolitan Institute of Medical Science, Hamamatsu University School of Medicine
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.COPD: Patients who receive home oxygen therapy according to stage IV chronic obstructive pulmonary disease. Includes users of non-invasive positive pressure ventilation.2.IPF: Patients with interstitial pneumonia diagnosed by Severity classification I to IV of idiopathic pulmonary fibrosis. 3.AP: A person who is diagnosed with aspiration pneumonia and starts home care after hospitalization.4.DM: Patients with diabetes stage 4 diabetic nephropathy third stage who need blood sugar/blood pressure control.5. ALS: A person who is able to visit an outpatient with a severity classification of 4 degrees or less by the Ministry of Health.6.HF: Those who is NYHA classification II-III of chronic heart failure due to angina, coronary artery disease, valvular disease, cardiomyopathy, etc.7.Lung ca: Those receiving cancer drug therapy due to lung cancer. 8.COVID-19 positive. Target selection criteria (1) Those who regularly visit the outpatient clinic and continue to receive medical treatment.(2)Those who can obtain the consent of the attending physician to participate in this study.(3)A person who can secure a place to install a tablet terminal and a set of measuring equipment in the target person's home.(4)Those who have no hindrance to cognitive function, have alternatives to limb functions, can self-measure daily blood pressure, oxygen saturation, etc., and can answer questions, and understand terminal operations.(5)Those who can use the long-term care insurance service, social resources, etc. regardless of the usage status, even during the research cooperation period.(6)Age 65 years old or older (However, only ALS must be aged 60 years old or older).

Exclusion criteria

Exclusion criteria: Exclusion criteria will be: 1. Those who are in the end-stage status 2. Those who are in a state of serious depression 3. A person who has a decline in cognitive functions or a decline in limb function and cannot obtain assistance in operating the telenursing devices. 4.Those who need hospital treatment

Design outcomes

Primary

MeasureTime frame
Acute exabertions

Secondary

MeasureTime frame
Self-care, health literacy, adherance, daily living status, ALD, self-management, self-efficacy, quality of life, feeling of safety, satisfactions, depression, daily monitoring status, disease stability, prescriptions and health-care fee.

Countries

Japan

Contacts

Public ContactTomoko Kamei

St. Luke's International University Graduate School Graduate School of Nursing Science

kamei@slcn.ac.jp03-5550-2283

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026